SERUM CYSTATIN C LEVELS AND LONG-TERM MORTALITY AMONG SUBJECTS WITH NORMAL CREATININE-BASED ESTIMATED GLOMERULAR FILTRATION RATES  by Lin, Jou-Wei et al.
A140.E1310
JACC March 9, 2010
Volume 55, issue 10A
 QUALITY OF CARE AND OUTCOMES ASSESSMENT 
SERUM CYSTATIN C LEVELS AND LONG-TERM MORTALITY AMONG SUBJECTS WITH NORMAL 
CREATININE-BASED ESTIMATED GLOMERULAR FILTRATION RATES
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Monday, March 15, 2010, 3:30 p.m.-4:30 p.m.
Session Title: Outcomes, Hypertension and Kidney Disease
Abstract Category: Outcomes Assessment
Presentation Number: 1194-166
Authors: Jou-Wei Lin, Cho-Kai Wu, Yu-Sheng Lin, Dept of Environmental and Occupational Health, Univ of North Texas Health, Fort Worth, TX, 
National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan,ROC
Objectives: The objective of this study was to evaluate the prognostic value of cystatin C (Cys-C) in the subjects with normal glomerular filtration 
rates (eGFR). 
Methods: We selected the subjects aged ≥ 40 in the Third National Health and Nutrition Examination Survey (NHANES III) who were found to 
have Modification of Diet in Renal Disease (MDRD) eGFR ≥ 60 ml/min/1.73m2. These subjects were categorized into the high (>90th percentile), 
medium (10~90th percentile), and low Cys-C levels (<10th percentile). All-cause and cause-specific mortality were obtained from the NHANES III-
linked follow-up file through December 31, 2000. Cox regression models, adjusted for age, sex, MDRD eGFR, the presence of microalbuminuria, and 
the status of diabetes, hypertension, and current smoking, were applied to estimate the hazard ratios (HR) and 95% confidence intervals (95% CI) of 
various types of mortality among the three Cys-C strata. 
Results: There were291, 2470, and 306 subjects with the high, medium, and low Cys-C levels, representing 6.57x106, 52.65x106, and 6.57 x 106 
adult US subjects. The serum Cys-C level was 1.29±0.010, 0.89±0.003, and 0.67±0.004 mg/L, respectively. A total of 300 cardiovascular events 
and 394 non-cardiovascular events developed within the 14-year follow-up. After adjustment for MDRD eGFR and other potential risk factors, the 
subjects with the high and medium Cys-C levels, as compared to those with the low Cys-C level, were found to have increased risk for all-cause 
mortality (high vs. low: HR: 3.68, 95% CI: 1.93~7.01, p < 0.001; medium vs. low: HR: 1.97, 95% CI: 1.02~3.80, p = 0.043), cardiovascular mortality 
(HR: 8.24, 95% CI: 2.53~26.8, p < 0.001; HR: 5.12, 95% CI: 1.52~17.2, p = 0.009), and cardiac mortality (HR: 21.7, 95% CI: 6.03~77.9, p <0.001; 
HR: 13.5, 95% CI: 3.45~53.2, p <0.001). Non-cardiovascular mortality was statistically higher in the high Cys-C group than in the low-level group 
(HR: 3.13, 95% CI: 1.37~7.11, p = 0.008). 
Conclusions: The results of the national cohort have demonstrated that serum Cys-C level is prognostic of long-term mortality in the subjects with 
relatively normal renal function, independent of conventional risk factors such as MDRD eGFR and microalbuminuria.
